Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 30, 2004
[Bronchioloalveolar carcinoma (BAC)]Akinobu Yoshimura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 13, 2006
[Current status and problems of anticancer drug-induced lung injuries]Shoji Kudoh, Akinobu Yoshimura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2003
[Idiopathic pulmonary fibrosis and lung cancer]Akinobu Yoshimura, Syoji Kudoh
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 3, 2004
[Current status and measures for lung injuries in cancer treatment]Shoji Kudoh, Akinobu Yoshimura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 27, 2003
[Iressa (gefitinib)]Shoji Kudoh, Akinobu Yoshimura, Akihiko Gemma
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|September 11, 2008
Unique medical education programs at Nippon Medical SchoolToshiro Shimura, Akinobu Yoshimura, Takuya Saito, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|March 9, 2013
Pitfalls in training simulated patients to respond appropriately to questions from medical students in family history-taking activities: the current situation surrounding the training of simulated patients for learning activities at Nippon Medical SchoolRyoko Aso, Chikako Inoue, Akinobu Yoshimura, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|February 1, 2013
Three dimensional computed tomography lung modeling is useful in simulation and navigation of lung cancer surgeryNorihiko Ikeda, Akinobu Yoshimura, Masaru Hagiwara, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|October 30, 2004
Cross-cultural validation of the Japanese Functional Assessment of Cancer Therapy-Anemia (FACT-An)Akinobu Yoshimura, Kunihiko Kobayashi, Hiyori Fumimoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Docetaxel in combination with either cisplatin or gemcitabine in unresectable non-small cell lung carcinoma: a randomized phase II study by the Japan Lung Cancer Cooperative Clinical Study GroupNobuyuki Katakami, Yuichi Takiguchi, Kozo Yoshimori, et al.
Pageof 6